On Wednesday, Following U.S. Stocks were among the “Top Gainers”: Impax Laboratories, (NASDAQ:IPXL), Bill Barrett, (NYSE:BBG), Accuray Incorporated, (NASDAQ:ARAY), Ultra Petroleum, (NYSE:UPL)
Impax Laboratories, (NASDAQ:IPXL), with shares inclined 9.80%, closed at $42.23, hitting new 52-week high of $42.75.
Bill Barrett, (NYSE:BBG), with shares jumped 9.26%, settled at $9.32.
Accuray Incorporated, (NASDAQ:ARAY), with shares climbed 3.76%, and closed at $8.83.
Ultra Petroleum, (NYSE:UPL), surged 8.29%, and closed at $15.55.
Latest NEWS regarding these Stocks are depicted underneath:
Impax Laboratories Inc. (NASDAQ:IPXL)
Impax Laboratories Inc. (IPXL), declared that it has accomplished its attainment of Tower Holdings, Inc. (counting operating auxiliaries CorePharma LLC and Amedra Pharmaceuticals LLC), and Lineage Therapeutics Inc. (together, the “Companies”). In connection with the closing of the attainment, Impax also declared that it is reshaping the operating and reporting structure of its two divisions – the Impax generic products division will now be known as “Impax Generics” and the Impax branded products division will now be known as “Impax Specialty Pharma”. In addition, Impax has launched a new corporate logo to better reflect the growth and future of the Corporation.
The privately-held Companies attained by Impax specialize in the development, manufacture and commercialization of complex generic and branded pharmaceutical products. This profitable and growing portfolio comprises of four branded products, counting the branded Albenza® franchise, Adrenaclick® and the related authorized generic, ten complementary commercialized generic products in addition to other near-term generic opportunities.
Impax Laboratories, Inc., a specialty pharmaceutical corporation, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division.
Bill Barrett Corp. (NYSE:BBG)
Formerly on February 25, Bill Barrett Corp. (BBG), stated 2014 results and declared the 2015 Operating Plan and Strategy.
2014 Production & Financial Results:
Oil, natural gas and NGL production totaled 9.1 MMBoe in 2014 contrast with 14.5 MMBoe in 2013, with the decrease in production attributable to asset sales accomplished at the end of 2013 and in the third quarter of 2014. Production from core assets raised 29% year over year, pro forma for asset sales. Fourth quarter 2014 production was 1.4 MMBoe. Exit rate production is estimated at about 15,600 Boe/d, counting about 11,000 Bbls/d oil, 18 MMcf/d natural gas and 1,600 Bbls/d NGLs. Fourth quarter and exit rate production comprise the influence of third party facility downtime, which affected net production for these periods by about 1,000 Boe/d.
Discretionary cash flow, (a non-GAAP measure, see the relevant reconciliation table below) for 2014 was $4.78 per diluted ordinary share, down from $5.92 per diluted ordinary share in 2013 mostly as a result of lower production due to asset sales. Lower production was partially offset by a 29% raise in the average realized price per barrel primarily as a result of the raised proportion of oil sales in the Corporation’s commodity mix, a 21% decline in interest expense and a 14% decline in general and administrative expenses (before non-cash, stock-based compensation.) Discretionary cash flow for the fourth quarter of 2014 was $0.80 per diluted ordinary share contrast with $1.62 per diluted ordinary share in the preceding year period.
Net revenue for 2014 was $15.1 million, or $0.31 per diluted ordinary share, contrast with a loss of $192.7 million, or ($4.06) per diluted ordinary share in 2013. Net revenue for 2014 and 2013 comprises impairment charges of $40.2 million (pre-tax) and $226.6 million (pre-tax), respectively, in addition to a derivative gain of $199.3 million (pre-tax) in 2014 and a derivative loss of $28.4 million (pre-tax) in 2013. Impairment charges in 2014 related primarily to the Powder River Basin asset sale, unfavorable drilling results in the Paradox Basin and certain unproved properties. Net revenue for the fourth quarter of 2014 was $89.1 million, or $1.84 per diluted ordinary share, which comprised of a non-cash derivative gain of $177.4 million. Adjusted net revenue (loss) (a non-GAAP measure, see the relevant reconciliation table below) was ($25.2) million in 2014 contrast with ($20.5) million in 2013. The larger loss in 2014 was primarily driven by a 34% raise in per unit depreciation, depletion and amortization expense contrast with 2013 due to a higher proportion of oil in the production mix. For the fourth quarter of 2014, adjusted net revenue (loss) was ($11.3) million or ($0.23) per diluted ordinary share. Adjusted net revenue (loss) removes the effect of unrealized derivative gains and losses and non-recurring charges such as impairment expenses, property sales and certain one-time items.
Accuray Incorporated (NASDAQ:ARAY)
Formerly on March 5, Accuray Incorporated (ARAY), and Christie InnoMed Inc. declared that they have reached sales agent contracts involving the CyberKnife® and TomoTherapy® System product portfolios in Canada . Under the terms of these contracts, Christie InnoMed will be the exclusive sales agent for Accuray products in this region.
Christie InnoMed develops, distributes, integrates and supports technological products and solutions that improve performance of Canadian healthcare institutions in the areas of medical imaging and healthcare administration solutions.
Accuray Incorporated (ARAY) is a radiation oncology corporation that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of assisting patients live longer, better lives. The corporation’s leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.
Ultra Petroleum Corp. (NYSE:UPL)
Formerly on February 19, Ultra Petroleum Corp. (UPL), stated 5.4 trillion cubic feet equivalent (Tcfe) of total proved reserves for the year-ended December 31, 2014 a 49 percent raise over 2013 oil and natural gas reserves of 3.6 Tcfe. More significantly, the pre-tax estimated future net cash flows discounted at ten percent (PV-10) of the corporation’s proved reserves raised to $7.1 billion from $4.1 billion, a 72 percent year-over-year raise. Ultra replaced 805 percent of 2014 production and achieved an all-in finding and development (F&D) cost of $0.75 per thousand cubic feet equivalent (Mcfe).
Ultra Petroleum’s reserves were calculated based on reference prices for oil and natural gas in accordance with SEC rules. These reference prices, before differentials, were $4.35 per Mmbtu Henry Hub (HHUB) for natural gas and $94.99 per barrel (Bbl) West Texas Intermediate (WTI) for oil. Applying regional market differentials together with appropriate adjustments for quality, energy content and transportation charges, the average prices for the corporation’s proved reserves were $4.32 per thousand cubic feet (Mcf) for natural gas and $80.62 per Bbl for oil.
Natural gas represents 90 percent of the corporation’s proved reserves, with 97 percent in Wyoming. Ultra’s 2014 proved developed (PD) reserves are 2.5 Tcfe, a 30 percent raise from 1.9 Tcfe in 2013. The proved undeveloped (PUD) reserves are 2.9 Tcfe, a 69 percent raise above year-ago levels, and represent 54 percent of total proved reserves.
Based on SEC guidelines, the corporation’s PUD reserves are limited to those locations that are planned to be developed within five years. Ultra’s 2.9 Tcfe of PUD reserves will require an estimated $3.37 billion of development capital over the next five years, resulting in an estimated average cost to develop of $1.16 per Mcfe. The future development capital is based on actual 2014 well costs and does not incorporate 2015 well cost reductions.
The corporation performed two sensitivities on proved reserves offered in the table below. The first is a downside case for proved reserves applying $3.50 per Mmbtu HHUB for natural gas and $60 per Bbl WTI for oil. Despite the 20 percent reduction in natural gas prices and 37 percent reduction in oil prices, Ultra’s reserves would only decrease by 5 percent.
The second sensitivity demonstrates the raise to proved reserves if the corporation adopted a larger capital plan. This sensitivity specifically comprises those additional locations that could be booked as proved, but are presently planned beyond the five year development plan used for 2014 reserves. Under this scenario, proved reserves would raise to over 9.1 Tcfe. This demonstrates the multi-year inventory of low-risk, high quality locations accessible to the corporation for future development.
Ultra Petroleum Corp., an independent oil and gas corporation, engages in the attainment, exploration, development, production, and operation of oil and natural gas properties in the United States. The corporation is listed on the New York Stock Exchange and trades under the ticker symbol “UPL”.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
